Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 3.27% is 82% above its 1-year average of 1.79%, near the high end of its 1-year range (0.00%–3.59%).
82.17% above its 12-month average of 1.79%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.78%.
RETURN ON ASSETS (ROA)
3.27%
RETURN ON ASSETS (ROA) AVG TTM
1.79%
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+82.17%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
1.23%
median of 710 covered companies
CURRENT VS SECTOR MEDIAN
+164.78%
vs the sector median at left
Oaktree Acquisition Corp. II
Market Cap
$264.51M
Return on Assets (ROA)
3.27%
TTM Avg
1.79%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.47M
Return on Assets (ROA)
3.34%
TTM Avg
2.20%
3Y Avg
2.20%
5Y Avg
2.20%
Market Cap
$264.38M
Return on Assets (ROA)
4.15%
TTM Avg
-42.24%
3Y Avg
-42.24%
5Y Avg
-42.24%
Market Cap
$263.53M
Return on Assets (ROA)
1.23%
TTM Avg
-16.10%
3Y Avg
-16.10%
5Y Avg
-16.10%
Market Cap
$265.95M
Return on Assets (ROA)
1.49%
TTM Avg
1.13%
3Y Avg
0.85%
5Y Avg
0.91%
Market Cap
$266.29M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.50M
Return on Assets (ROA)
3.52%
TTM Avg
1.73%
3Y Avg
-6009.49%
5Y Avg
-6009.49%
Market Cap
$262.04M
Return on Assets (ROA)
2.18%
TTM Avg
0.24%
3Y Avg
0.16%
5Y Avg
0.16%
Market Cap
$261.73M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oaktree Acquisition Corp. II (OACC) | $264.51M | 3.27% | 1.79% | N/A | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 3.34% | 2.20% | 2.20% | 2.20% |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 4.15% | -42.24% | -42.24% | -42.24% |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 1.23% | -16.10% | -16.10% | -16.10% |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.95M | 1.49% | 1.13% | 0.85% | 0.91% |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.29M | N/A | N/A | N/A | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.50M | 3.52% | 1.73% | -6009.49% | -6009.49% |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.04M | 2.18% | 0.24% | 0.16% | 0.16% |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A | N/A | N/A | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.45M | 1.17% | 0.72% | 0.72% | 0.36% |
ROA
3.3%
ROE
3.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.59% |
| 2024-12-31 | 0.00% |
